UPDATE: PMV Pharma (PMVP) - The Data Gets Stronger...
... But The Smart Money Just Ran for the Exits
PMV Pharmaceuticals just dropped a triad of SEC filings that encapsulates the dichotomy of small-cap clinical biotech. The structural biology is working better than expected, and the regulatory moat is deepening, but a top-tier institutional investor just dumped their entire position.
